Aphria is engaged in the production, supply and sale of medical cannabis in Canada. Co.'s medical cannabis is 100% greenhouse grown and comes in a range of products such as capsules, oral solutions, syringes and vaporizers. Co.'s cannabis capsules contain a precise dose of active cannabinoids in the form of purified cannabis oil. Co.'s oral solution contains purified cannabis oil in a liquid form. Co.'s syringe products are versatile and can be consumed in various forms, including orally or heated at a high temperature. Co.'s single-unit vaporizer cartridges are pre-filled with purified cannabis oil made from cannabis plant extract and natural terpenes.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.